Literature DB >> 18286357

Formation of stable submicron protein particles by thin film freezing.

Joshua D Engstrom1, Edwina S Lai, Baltej S Ludher, Bo Chen, Thomas E Milner, Robert O Williams, G Barrie Kitto, Keith P Johnston.   

Abstract

PURPOSE: Highly stable, submicron lactate dehydrogenase (LDH) and lysozyme particles may be produced by thin film freezing (TFF) of aqueous solutions followed by lyophilization.
METHODS: The LDH activity was determined by measuring the decrease in absorbance of NADH over time for the reaction of pyruvate to lactate. For lysozyme the particle morphology was determined by scanning electron microscopy (SEM) and compared with the specific surface area (BET) and the particle size, as measured by laser light scattering,
RESULTS: Protein particles with an average diameter of 300 nm and 100% enzyme activity upon reconstitution (for LDH) were formed by TFF. Droplets of protein solutions, 3.6 mm in diameter, spread upon impact with 223 and 133 K metal surfaces to form cylindrical disks with thicknesses of 200-300 microm. Calculated cooling rates of the disks of 10(2) K/s were confirmed experimentally with infrared measurements.
CONCLUSIONS: The cooling rates of 10(2) K/s, intermediate to those in lyophilization (1 K/min) and spray freeze-drying (SFD) (10(6) K/s), were sufficiently fast to produce sub-micron protein particles with surface areas of 31-73 m2/g, an order of magnitude higher than in lyophilization. In addition, the low surface area/volume ratio (32-45 cm(-1)) of the gas-liquid interface led to minimal protein adsorption and denaturation relative to SFD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18286357     DOI: 10.1007/s11095-008-9540-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  37 in total

Review 1.  Biopharmaceutical powders: particle formation and formulation considerations.

Authors:  Y F Maa; S J Prestrelski
Journal:  Curr Pharm Biotechnol       Date:  2000-11       Impact factor: 2.837

Review 2.  Microneedles for transdermal drug delivery.

Authors:  Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2004-03-27       Impact factor: 15.470

3.  Stable high surface area lactate dehydrogenase particles produced by spray freezing into liquid nitrogen.

Authors:  Josh D Engstrom; Dale T Simpson; Carrie Cloonan; Edwina S Lai; Robert O Williams; G Barrie Kitto; Keith P Johnston
Journal:  Eur J Pharm Biopharm       Date:  2006-08-17       Impact factor: 5.571

4.  Surface-induced denaturation of proteins during freezing and its inhibition by surfactants.

Authors:  B S Chang; B S Kendrick; J F Carpenter
Journal:  J Pharm Sci       Date:  1996-12       Impact factor: 3.534

5.  The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody.

Authors:  J D Andya; Y F Maa; H R Costantino; P A Nguyen; N Dasovich; T D Sweeney; C C Hsu; S J Shire
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

6.  Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres.

Authors:  X M Lam; E T Duenas; J L Cleland
Journal:  J Pharm Sci       Date:  2001-09       Impact factor: 3.534

7.  Maintenance of quaternary structure in the frozen state stabilizes lactate dehydrogenase during freeze-drying.

Authors:  T J Anchordoquy; K I Izutsu; T W Randolph; J F Carpenter
Journal:  Arch Biochem Biophys       Date:  2001-06-01       Impact factor: 4.013

8.  Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state.

Authors:  T J Anchordoquy; J F Carpenter
Journal:  Arch Biochem Biophys       Date:  1996-08-15       Impact factor: 4.013

9.  Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.

Authors:  Yuh-Fun Maa; Lu Zhao; Lendon G Payne; Dexiang Chen
Journal:  J Pharm Sci       Date:  2003-02       Impact factor: 3.534

10.  Stability and surface activity of lactate dehydrogenase in spray-dried trehalose.

Authors:  M Adler; G Lee
Journal:  J Pharm Sci       Date:  1999-02       Impact factor: 3.534

View more
  9 in total

1.  Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and in vivo bioavailability.

Authors:  Maria A Miller; Tarik A Khan; Kevin J Kaczorowski; Brian K Wilson; Aileen K Dinin; Ameya U Borwankar; Miguel A Rodrigues; Thomas M Truskett; Keith P Johnston; Jennifer A Maynard
Journal:  J Pharm Sci       Date:  2012-07-06       Impact factor: 3.534

2.  Respirable low-density microparticles formed in situ from aerosolized brittle matrices.

Authors:  Alan B Watts; Yi-Bo Wang; Keith P Johnston; Robert O Williams
Journal:  Pharm Res       Date:  2012-11-15       Impact factor: 4.200

3.  In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization.

Authors:  Yi-Bo Wang; Alan B Watts; Jay I Peters; Sha Liu; Ayesha Batra; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2014-05-14       Impact factor: 3.246

4.  A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.

Authors:  Xinran Li; Sachin G Thakkar; Tinashe B Ruwona; Robert O Williams; Zhengrong Cui
Journal:  J Control Release       Date:  2015-02-28       Impact factor: 9.776

5.  The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.

Authors:  Sachin G Thakkar; Tinashe B Ruwona; Robert O Williams; Zhengrong Cui
Journal:  Hum Vaccin Immunother       Date:  2017-01-04       Impact factor: 3.452

6.  Low viscosity highly concentrated injectable nonaqueous suspensions of lysozyme microparticles.

Authors:  Maria A Miller; Joshua D Engstrom; Baltej S Ludher; Keith P Johnston
Journal:  Langmuir       Date:  2010-01-19       Impact factor: 3.882

7.  Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers.

Authors:  Josh D Engstrom; Jasmine M Tam; Maria A Miller; Robert O Williams; Keith P Johnston
Journal:  Pharm Res       Date:  2008-08-29       Impact factor: 4.200

8.  Next-Generation COVID-19 Vaccines Should Take Efficiency of Distribution into Consideration.

Authors:  Khaled AboulFotouh; Zhengrong Cui; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2021-04-09       Impact factor: 3.246

Review 9.  The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation.

Authors:  Jieliang Wang; Ying Peng; Haiyue Xu; Zhengrong Cui; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2020-08-05       Impact factor: 3.246

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.